Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

This study is testing an investigational injection called TQC2731 for adults with chronic sinusitis and nasal polyps that haven't responded well to standard treatments. The goal is to see if this new medication, which blocks a specific inflammation pathway, can reduce polyp size …

This is the first human study testing a new cancer drug called TQB2922, given as an injection under the skin. Researchers will enroll 42 adults with advanced non-small cell lung cancer to check how safe the drug is and how the body processes it. The main goal is to find the right…

This study is testing an investigational drug called TQB2934 for people with systemic light chain amyloidosis that has come back or stopped responding to prior treatments. The main goals are to find a safe and effective dose and to see if the drug can help clear the harmful prote…

This study is testing whether adding two new drugs (TQB2868 and anlotinib) to standard chemotherapy helps people with advanced pancreatic cancer live longer. About 566 participants with newly diagnosed metastatic pancreatic cancer will receive either the new drug combination or s…